Kangmei Pharma | 600518 - Gross Profit On Sales

Stock Price
1.92
Daily Change
0.02 1.05%
Monthly
0%
Yearly
-16.16%
Q1 Forecast
1.86

Kangmei Pharma reported CNY270.29M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.95M 1.18M Jun/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Genomma Lab Internacional MXN 2.84B 133.26M Sep/2025
Hypermarcas BRL 1.36B 66.95M Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Jiangsu Hengrui CNY 6.36B 1.15B Sep/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Moderna USD 809M 791M Sep/2025
Organon & Co USD 857M 17M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Sh Fosun Pharma CNY 4.8B 93.72M Sep/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.37B 38.6M Sep/2025
Wuxi Apptec CNY 6.12B 958.48M Sep/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025